Ask about this productRelated genes to: VEGFR1 antibody
- Gene:
- FLT1 NIH gene
- Name:
- fms related tyrosine kinase 1
- Previous symbol:
- FLT
- Synonyms:
- VEGFR1
- Chromosome:
- 13q12.3
- Locus Type:
- gene with protein product
- Date approved:
- 1986-01-01
- Date modifiied:
- 2019-04-23
Related products to: VEGFR1 antibody
Related articles to: VEGFR1 antibody
- - Source: PubMed
Publication date: 2026/08/12
Lu LiuWu YinLu CaichunLiang FeitengGu ShixingSun ShengTang QiangTang Qianli - Jiao-Ai Decoction (JAD), a classic Traditional Chinese Medicine (TCM) formula, has been applied traditionally for treating gynecological conditions such as menorrhagia, post-abortion bleeding, and threatened abortion (TA). Clinically, it yields an efficacy rate of over 90% for TA treatment, yet its associated molecular events have not been characterized. - Source: PubMed
Publication date: 2026/08/11
Hu XinruYun JiaqiDeng JiaLiu ChenNiu XueyuGao JialinLu YuechunOu HanWang ZiqiGeng TingZhang YiZhang Li - Venous malformations (VMs) are congenital vascular anomalies characterized by abnormal vascular proliferation, with limb VMs often leading to functional impairment and physical discomfort. However, the cellular heterogeneity and underlying molecular mechanisms driving pathological proliferation in limb VMs remain incompletely elucidated. - Source: PubMed
Publication date: 2026/08/07
Lin JunjieLiu TingtingFang BinFeng XiaojuanJiao WentingChen ChangkuanDing YaqingZhu GaozanWang WenqiuLiu WenboLi YuanqiHou ShoufuWei JiansheQiao Junbo - Current UK guidelines recommend measurement of symphyseal fundal height and measurement of maternal blood pressure and urinalysis, with the aim of detecting women at increased risk of fetal growth restriction (FGR) and pre-eclampsia. Between 2008 and 2013, we conducted a prospective cohort study recruiting 4512 nulliparous women at the Rosie Hospital, Cambridge, where we performed serial ultrasonic imaging and serial blood sampling and generated a novel screening test for pre-eclampsia and FGR. The method involved measuring the ratio of two placental biomarkers (soluble fms-like tyrosine kinase receptor-1 and placenta growth factor) at ~36 weeks of gestational age (wkGA) and combining the result with maternal characteristics and ultrasonic imaging. Women who screened positive had a ~50% risk of a composite outcome, consisting of pre-eclampsia±delivery of a baby with a birth weight <3rd percentile for sex and gestational age±perinatal morbidity or death. It is plausible that screening and intervention using this method might improve pregnancy outcome. - Source: PubMed
Publication date: 2026/08/07
Smith Gordon C SSutton-Cole AmyDyer EllenSovio UllaCook EmmaWhite Ian RCharnock-Jones D Stephen - The common marmoset (Callithrix jacchus) is a valuable non-human primate model organism with a long history of use in biomedical research, including investigating diseases with an immune component. However, prior to this effort, there has been a lack of sufficiently validated tools to quantify inflammatory markers in the common marmoset using a multiplex approach. We provide a cross-species reactivity validation of a human-specific multiplex analysis strategy that allows for the assessment of 20 distinct inflammatory analytes in a small volume of plasma isolated from common marmoset blood. We used this novel approach to perform an assessment of the impact of sex as a biological variable on a subset of these inflammatory analytes. We found that endogenous plasma levels of the following analytes are not significantly different between female and male marmosets: CRP, ICAM-1, VCAM-1, IL-13, IL-8, MIP-1β, IFN-g, IL-4, VEGF-A, FLT-1, and bFGF. These findings demonstrate the utility of our validated method for quantifying marmoset inflammatory markers. - Source: PubMed
Publication date: 2026/07/17
Rogers Donald RBerryman Charleston DRivero Victor JRyan Sydney EHayer Shivdeep SConrin MackenzieJabenis AliyahRauter Claudia MBuhrman Jonathan DClayton Jonathan BDenton Paul W